DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Stangier J, Stähle H, Rathgen K. et al.
Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment.
J Clin Pharmacol 2008;
48: 1411-1419. doi: https://doi.org/10.1177/0091270008324179
We do not assume any responsibility for the contents of the web pages of other providers.